Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Umbilical Cord Blood Transfusion for Cerebral Palsy
NCT03791372Phase 1Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Oct 2017
- Primary completion
- Oct 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of autologous umbilical cord blood in cerebral palsy (CP) (2 arms), sponsored by Guangdong Women and Children Hospital. Primary endpoints: Gross Motor Function Classification System at 30 months and Gesell Developmental Scale at 30 months. Status: unknown.
02
Drugs
autologous umbilical cord blood
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03791372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791372.